发明授权
US09447038B2 Substituted B-amino acid derivatives as CXCR3 receptor antagonists
有权
取代的B-氨基酸衍生物作为CXCR3受体拮抗剂
- 专利标题： Substituted B-amino acid derivatives as CXCR3 receptor antagonists
- 专利标题（中）： 取代的B-氨基酸衍生物作为CXCR3受体拮抗剂
-
申请号： US14546087申请日： 2014-11-18
-
公开(公告)号： US09447038B2公开(公告)日： 2016-09-20
- 发明人: Imre Bata , Veronika Bartane Bodor , Attila Vasas , Peter Buzder-Lantos , Gyorgy Ferenczy , Zsuzsanna Tomoskozi , Gabor Szeleczky , Zsuzsanna Szamosvolgyi
- 申请人： SANOFI
- 申请人地址： FR Paris
- 专利权人： Sanofi
- 当前专利权人： Sanofi
- 当前专利权人地址： FR Paris
- 代理商 Kelly L. Bender
- 优先权： EP12462009 20120523
- 主分类号： C07D409/12
- IPC分类号： C07D409/12 ; C07D405/12 ; C07D207/404 ; C07D233/72 ; C07D407/12 ; C07D239/54 ; C07D233/74
摘要：
The present invention relates to compounds of formula 1 that are useful for the preventive and/or therapeutic treatment of diseases caused by abnormal activation of CXCR3 chemokines. The invention relates furthermore to a process for the preparation of said compounds, to pharmaceutical compositions containing said compounds and to novel intermediates used in the preparation of said compounds.
公开/授权文献
信息查询
